Related Experiment Video
Updated: Jan 31, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Rare Association of Mucolipidosis III alpha/beta with Dilated Cardiomyopathy
Min Jung Kwak1, Hye Won Lee2, Young Mi Kim1
1Department of Pediatrics, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Republic of Korea.
Abstract:
Mucolipidosis III alpha/beta (ML III alpha/beta) is an autosomal recessive lysosomal storage disorder caused by N-acetylglucosamine-1-phosphotransferase (GlcNAc-phosphotransferase) deficiency. It is characterized by coarse facial features, developmental delay, short stature, and skeletal deformities. Its cardiovascular symptoms include valvular thickening or hypertrophic cardiomyopathy. A 32-year-old female patient received heart transplantation due to end-stage heart failure caused by dilated cardiomyopathy (DCM). We performed whole exome sequencing to determine the etiology of DCM and/or skeletal deformities. The test revealed c.2715+1G>A and c.3173C>G mutations in the GNPTAB gene encoding the alpha and beta subunits of GlcNAc-phosphotransferase. Finally, she was diagnosed with ML III alpha/beta. This report describes a rare case of ML III alpha/beta associated with DCM. Our findings expand the clinical spectrum of ML III alpha/beta.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy VI: Nursing Management

